Belite Bio, Inc BLTE
154.01 USD +1.84 (+1.21%)
At closeNov 4, 2026, 4:00 PM EST
154.01 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
150.65 Day range 156.97
102.00 52-week range 200.00
- YTD
- -3.72%
- 1 year
- +38.65%
Financial health
Altman Z-Score
246.28 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -69.2×
FY 2020 5y median -47.8× FY 2025
P/S 0.0×
FY 2020 5y median 0.0× FY 2025
P/B 7.0×
FY 2020 5y median 13.2× FY 2025
P/FCF -144×
FY 2020 5y median -50.8× FY 2025
EV/EBITDA -65.0×
FY 2020 5y median -45.1× FY 2025
EV/Sales 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -0.7%
FY 2020 5y median -2.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020 5y median 0.0% FY 2025
ROE -10.1%
FY 2020 5y median -24.8% FY 2025
ROIC -10.9%
FY 2020 5y median -30.3% FY 2025
ROA -9.9%
FY 2020 5y median -28.6% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income -110.5%
FY 2020 FY 2025
EPS (diluted) -95.8%
FY 2020 FY 2025
Free Cash Flow -26.5%
FY 2020 FY 2025
Financial Health
Current Ratio 50.0×
FY 2020 5y median 24.3× FY 2025
Quick Ratio 50.0×
FY 2020 5y median 24.3× FY 2025
Debt / Equity 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 4.6×
FY 2020 5y median 2.8× FY 2025
Interest Coverage 0.0×
FY 2020 5y median -801× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31